Background Covid-19 disease is caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2). Although corticosteroids have shown some promising results in Covid-19 …

The roles of methylprednisolone in treatment of patients with COVID-19 remain unclear. The
aim of this study was to evaluate the efficacy and safety of methylprednisolone in treatment …

Importance Communication and adoption of modern study design and analytical techniques
is of high importance for the improvement of clinical research from observational data …

Introduction We conducted a comprehensive literature review to synthesize evidence for the
relationship between corticosteroid use and mortality in patients with COVID-19. Methods …

Aim: To evaluate the efficacy and safety of corticosteroids for treating hospitalized COVID-19
patients. Materials & methods: Efficacy outcomes included time to negative SARS-CoV-2 …

Since the outbreak of COVID-19, research has been focused on establishing effective
treatments, especially for patients with severe pneumonia and hyperinflammation. The role …

BACKGROUND Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the
causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic …

Background: This study evaluated the clinical outcomes of patients with severe COVID-19
pneumonia treated with remdesivir plus standard corticosteroid treatment (SCT) or with …

Objectives This study was designed to compare the efficacy and safety of
methylprednisolone and tocilizumab in the treatment of patients with severe COVID-19 …

Based on Russian and the Middle East corticosteroids trials in MERS-CoV, we performed
methylprednisolone pulse therapy (MPT), resulting in a clinical trial still without result. Our …